B-62/100

Is Align Technology (ALGN) a risky stock?

Sector: Health Care Price: $177.26 Composite: 62/100

As of July 21, 2026, Clavix grades Align Technology (ALGN) B- for risk, a composite score of 62 out of 100 on an A+ to F scale, which puts ALGN in the "average" band. The grade is a risk read for educational purposes, not a buy or sell recommendation.

Grade as of July 21, 2026. Clavix regrades every trading day.

The five risk dimensions behind ALGN's grade

Each Clavix grade is a composite of five independent reads. Higher is safer. Here is how ALGN scores on each, as of July 21, 2026.

Financial healthbalance sheet, margins, cash flow
71
News sentimentscored, sourced recent coverage
46
Macro exposuresensitivity to rates, dollar, oil
60
Sector resiliencestrength vs the broad market
61
Price stabilitydrawdown and volatility
42

What's moving ALGN's risk right now

Company-specific signals Clavix flags behind ALGN's current grade, drawn from recent news and filings as of July 21, 2026.

Earnings & results · mixed signal

Disney, Sphere, Lionsgate, Align and Reservoir have been highlighted in this Industry Outlook article.

Macro · mixed signal

Macro crosscurrents are partially offsetting each other, leaving near-term sector direction unclear.

What a B- grade means

On the Clavix A+ to F scale, ALGN's composite of 62 falls in the C band (50–64), read as "average." The scale is fixed, so the meaning never moves.

A+AA-B+BB-C+CC-D+DD-F
Get Clavix on iPhone → Or grade your whole portfolio free, no account needed.

This page is generated from Clavix's own risk model and is for educational purposes only. It is not investment advice or a recommendation to buy or sell ALGN or any security. Grades are risk indicators, not predictions of return. Data may be delayed.